Table 2.
Statistical characteristics of QSAR models for 6-pack end points evaluated by 5-fold external cross-validation.
End point | CCR | Se | Sp | PPV | NPV | Coverage | Number of compounds |
---|---|---|---|---|---|---|---|
Skin sensitization | 0.70 | 0.66 | 0.75 | 0.71 | 0.75 | 0.96 | 1,000 |
Skin irritation/corrosion | 0.72 | 0.77 | 0.66 | 0.69 | 0.74 | 0.94 | 1,012 |
Eye irritation/corrosion | 0.72 | 0.72 | 0.71 | 0.71 | 0.71 | 0.95 | 3,547 |
Acute dermal | 0.76 | 0.74 | 0.78 | 0.77 | 0.75 | 0.93 | 2,622 |
Acute inhalation | 0.74 | 0.69 | 0.80 | 0.77 | 0.72 | 0.95 | 681 |
Acute oral | 0.77 | 0.85 | 0.70 | 0.79 | 0.78 | 0.95 | 8,442 |
Note: CCR, correct classification rate; NPV, negative predictive value; PPV, positive predictive value; QSAR, quantitative structure–activity relationship; Se, sensitivity; Sp, specificity.